Pure Global
NCT06338358

Understanding Participation Habits Among Plaque Psoriasis Patients

In the Patient's Words: Understanding Patient Participation and Engagement in Plaque Psoriasis Clinical Trials
Power Life Sciences Inc.·ClinicalTrials.govNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Plaque Psoriasis
Study type
Observational
Sponsor & location
Primary sponsor
Power Life Sciences Inc.
Location
San Francisco, United States of America
Timeline & enrollment
Phase
N/A
Start date
Apr 01, 2025
End date
Apr 01, 2027
Enrollment
500 participants
Primary outcome

Rate of patients who decide to enroll in a plaque psoriasis clinical research.,Number of plaque psoriasis study participants who remain in clinical study until completion.

Summary

The study intends to investigate the personal experiences of plaque psoriasis patients who
 take part in a separate clinical study including a specific medication intervention. The
 major focus will be on closely following individuals' rates of trial completion and
 withdrawal.
 
 The data collected from this study will help improve future outcomes for all plaque psoriasis
 as well as those in under-represented demographic groups.

ICD-10 classifications
PsoriasisLarge plaque parapsoriasisOther psoriasisSmall plaque parapsoriasisArthropathic psoriasis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06338358
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06338358 through Pure Global AI's free database. This phase not specified trial is sponsored by Power Life Sciences Inc. and is currently Not yet recruiting. The study focuses on Plaque Psoriasis. Target enrollment is 500 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.